搜索临床试验以:奥拉帕尼片剂量
总计11900个结果
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United Kingdom完全的
-
Beijing Tiantan HospitalNeuroDawn Pharmaceutical Co., Ltd.招聘中
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.完全的
-
Duke UniversityAstraZeneca完全的
-
The Hospital for Sick ChildrenInternational Centre for Diarrhoeal Disease Research, Bangladesh; The Sprinkles Global Health...完全的
-
Tianjin Medical University Cancer Institute and...招聘中
-
Istituti Ospitalieri di Cremona未知
-
National Cancer Institute (NCI)主动,不招人去势抵抗性前列腺癌 | 转移性前列腺癌 | IV 期前列腺腺癌 AJCC v7 | 伴有神经内分泌分化的晚期前列腺癌 | 具有神经内分泌分化的转移性前列腺癌 | 前列腺癌伴神经内分泌分化美国
-
AstraZeneca主动,不招人
-
AstraZeneca主动,不招人乳腺癌美国, 比利时, 意大利, 西班牙, 英国, 德国, 奥地利, 以色列, 澳大利亚
-
Italian Sarcoma GroupAstraZeneca; PharmaMar主动,不招人
-
Hospices Civils de LyonFondation Apicil; Fondation Motrice完全的
-
Henry Ford Health System终止
-
Janssen Research & Development, LLC完全的
-
University of Texas Southwestern Medical Center撤销
-
National Cancer Institute, Naples招聘中
-
AZ-VUBAstraZeneca; Kom Op Tegen Kanker招聘中
-
AstraZenecaMyriad Genetic Laboratories, Inc.撤销
-
Overseas Pharmaceuticals, Ltd.Virginia Contract Research Organization Co., Ltd.终止
-
Nordsjaellands Hospital完全的
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
University of Witten/HerdeckeSysba solutions GmbH; Murtfeldt Kunststoffe GmbH & Co. KG完全的
-
SMART Clinical Products BVZiekenhuis Oost-Limburg完全的
-
National Cancer Institute (NCI)主动,不招人晚期恶性实体瘤 | 难治性恶性实体瘤 | 不可切除的恶性实体肿瘤 | 转移性恶性实体瘤美国
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University尚未招聘
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.招聘中
-
The Netherlands Cancer Institute完全的